Skip to main content
Top
Published in: Digestive Diseases and Sciences 5/2013

01-05-2013 | Original Article

Functional Roles of TGF-β1 in Intestinal Epithelial Cells Through Smad-Dependent and Non-Smad Pathways

Authors: Yumi Yamada, Hirosato Mashima, Toshitaka Sakai, Tamotsu Matsuhashi, Mario Jin, Hirohide Ohnishi

Published in: Digestive Diseases and Sciences | Issue 5/2013

Login to get access

Abstract

Background and Aims

Transforming growth factor-β1 (TGF-β1) is one of the growth factors expressed in the gut, and has been shown to play an important role in intestinal mucosal healing. We investigated the effects of TGF-β1 on the cellular functions of intestinal epithelial cells, and also evaluated its signaling pathways in these cells.

Methods

We used the rat IEC-6 intestinal epithelial cell line for these studies. The expression of TGF-β1/Smad signaling molecules was examined. We evaluated the effect of TGF-β1 on the proliferation and differentiation by the BrdU incorporation assay and real-time PCR. We manipulated the expression levels of Smad2 and Smad3 using an adenovirus system and small interfering RNA to examine the signaling pathways. The expression of Smad2 and Smad3 along the crypt-villus axis was also examined in the murine intestine.

Results

IEC-6 cells produced TGF-β1 and expressed functional TGF-β/Smad signaling molecules. The addition of TGF-β1 in the culture medium suppressed the proliferation and increased the expression of a differentiation marker of enterocytes, in a dose-dependent manner. The adenovirus-mediated and small interfering RNA-mediated studies clearly showed that the growth inhibitory effect and the promotion of differentiation were exerted through a Smad3-dependent and a Smad2-dependent pathway, respectively. IEC-6 cells exhibited upregulated expression of an inhibitory Smad (Smad7) as a form of negative feedback via a non-Smad pathway. Smad2 was predominantly expressed in villi, and Smad3 in crypts.

Conclusions

TGF-β1 regulates the cellular functions of intestinal epithelial cells through both Smad-dependent and non-Smad pathways.
Literature
1.
go back to reference Derynck R, Miyazono K, eds. TGF-β and the TGF-β family. New York: Cold Spring Harbor Laboratory Press; 2008. Derynck R, Miyazono K, eds. TGF-β and the TGF-β family. New York: Cold Spring Harbor Laboratory Press; 2008.
2.
go back to reference Moustakas A, Heldin C-H. The regulation of TGFβ signal transduction. Development. 2009;136:3699–3714.PubMedCrossRef Moustakas A, Heldin C-H. The regulation of TGFβ signal transduction. Development. 2009;136:3699–3714.PubMedCrossRef
3.
go back to reference Wharton K, Derynck R. TGFβ family signaling: novel insights in development and disease. Development. 2009;136:3691–3697.PubMedCrossRef Wharton K, Derynck R. TGFβ family signaling: novel insights in development and disease. Development. 2009;136:3691–3697.PubMedCrossRef
5.
go back to reference Hall PA, Coates PJ, Ansari B, Hopwood D. Regulation of cell number in the mammalian gastrointestinal tract: the importance of apoptosis. J Cell Sci. 1994;107:3569–3577.PubMed Hall PA, Coates PJ, Ansari B, Hopwood D. Regulation of cell number in the mammalian gastrointestinal tract: the importance of apoptosis. J Cell Sci. 1994;107:3569–3577.PubMed
6.
go back to reference Beck PL, Rosenberg IM, Xavier RJ, Koh T, Wong JF, Podolsky DK. Transforming growth factor-β mediates intestinal healing and susceptibility to injury in vitro and in vivo through epithelial cells. Am J Pathol. 2003;162:597–608.PubMedCrossRef Beck PL, Rosenberg IM, Xavier RJ, Koh T, Wong JF, Podolsky DK. Transforming growth factor-β mediates intestinal healing and susceptibility to injury in vitro and in vivo through epithelial cells. Am J Pathol. 2003;162:597–608.PubMedCrossRef
7.
go back to reference Howarth GS, Shoubridge CA. Enhancement of intestinal growth and repair by growth factors. Curr Opin Pharmacol. 2001;1:568–574.PubMedCrossRef Howarth GS, Shoubridge CA. Enhancement of intestinal growth and repair by growth factors. Curr Opin Pharmacol. 2001;1:568–574.PubMedCrossRef
8.
go back to reference Barnard JA, Beauchamp RD, Coffey RJ, Moses HL. Regulation of intestinal epithelial cell growth by transforming growth factor type beta. Proc Natl Acad Sci USA. 1989;86:1578–1582.PubMedCrossRef Barnard JA, Beauchamp RD, Coffey RJ, Moses HL. Regulation of intestinal epithelial cell growth by transforming growth factor type beta. Proc Natl Acad Sci USA. 1989;86:1578–1582.PubMedCrossRef
9.
go back to reference Sturm A, Dignass AU. Epithelial restitution and wound healing in inflammatory bowel disease. World J Gastroenterol. 2008;14:348–353.PubMedCrossRef Sturm A, Dignass AU. Epithelial restitution and wound healing in inflammatory bowel disease. World J Gastroenterol. 2008;14:348–353.PubMedCrossRef
10.
go back to reference Barnard JA, Warwick GJ, Gold LI. Localization of transforming growth factor beta isoforms in the normal murine small intestine and colon. Gastroenterology. 1993;105:67–73.PubMed Barnard JA, Warwick GJ, Gold LI. Localization of transforming growth factor beta isoforms in the normal murine small intestine and colon. Gastroenterology. 1993;105:67–73.PubMed
11.
go back to reference Datto MB, Frederick JP, Pan L, Borton AJ, Zhuang Y, Wang X-F. Targeted disruption of Smad3 reveals an essential role in transforming growth factor β-mediated signal transduction. Mol Cell Biol. 1999;19:2495–2504.PubMed Datto MB, Frederick JP, Pan L, Borton AJ, Zhuang Y, Wang X-F. Targeted disruption of Smad3 reveals an essential role in transforming growth factor β-mediated signal transduction. Mol Cell Biol. 1999;19:2495–2504.PubMed
12.
go back to reference Piek E, Ju WJ, Heyer J, et al. Functional characterization of transforming growth factor β signaling in Smad2- and Smad3-deficient fibroblasts. J Biol Chem. 2001;276:19945–19953.PubMedCrossRef Piek E, Ju WJ, Heyer J, et al. Functional characterization of transforming growth factor β signaling in Smad2- and Smad3-deficient fibroblasts. J Biol Chem. 2001;276:19945–19953.PubMedCrossRef
13.
go back to reference Ju W, Ogawa A, Heyer J, et al. Deletion of Smad2 in mouse liver reveals novel functions in hepatocyte growth and differentiation. Mol Cell Biol. 2006;26:654–667.PubMedCrossRef Ju W, Ogawa A, Heyer J, et al. Deletion of Smad2 in mouse liver reveals novel functions in hepatocyte growth and differentiation. Mol Cell Biol. 2006;26:654–667.PubMedCrossRef
14.
go back to reference Goto D, Yagi K, Inoue H, et al. A single missense mutant of Smad3 inhibits activation of both Smad2 and Smad3, and has a dominant negative effect on TGF-b signals. FEBS Lett. 1998;430:201–204.PubMedCrossRef Goto D, Yagi K, Inoue H, et al. A single missense mutant of Smad3 inhibits activation of both Smad2 and Smad3, and has a dominant negative effect on TGF-b signals. FEBS Lett. 1998;430:201–204.PubMedCrossRef
15.
go back to reference Ohnishi H, Miyata T, Yasuda H, et al. Distinct roles of Smad2-, Smad3-, and ERK-dependent pathways in transforming growth factor-beta1 regulation of pancreatic stellate cellular functions. J Biol Chem. 2004;279:8873–8878.PubMedCrossRef Ohnishi H, Miyata T, Yasuda H, et al. Distinct roles of Smad2-, Smad3-, and ERK-dependent pathways in transforming growth factor-beta1 regulation of pancreatic stellate cellular functions. J Biol Chem. 2004;279:8873–8878.PubMedCrossRef
16.
go back to reference Mashima H, Ueda N, Ohno H, et al. A novel mitochondrial Ca2+-dependent solute carrier in the liver identified by mRNA differential display. J Biol Chem. 2003;278:9520–9527.PubMedCrossRef Mashima H, Ueda N, Ohno H, et al. A novel mitochondrial Ca2+-dependent solute carrier in the liver identified by mRNA differential display. J Biol Chem. 2003;278:9520–9527.PubMedCrossRef
17.
go back to reference Gassler N, Newrzella D, Böhm C, et al. Molecular characterisation of non-absorptive and absorptive enterocytes in human small intestine. Gut. 2006;55:1084–1089.PubMedCrossRef Gassler N, Newrzella D, Böhm C, et al. Molecular characterisation of non-absorptive and absorptive enterocytes in human small intestine. Gut. 2006;55:1084–1089.PubMedCrossRef
18.
go back to reference Brown KA, Pietenpol JA, Moses HL. A tale of two proteins: differential roles and regulation of Smad2 and Smad3 in TGF-β signaling. J Cell Biochem. 2007;101:9–33.PubMedCrossRef Brown KA, Pietenpol JA, Moses HL. A tale of two proteins: differential roles and regulation of Smad2 and Smad3 in TGF-β signaling. J Cell Biochem. 2007;101:9–33.PubMedCrossRef
19.
go back to reference Afrakhte M, Morén A, Jossan S, et al. Induction of inhibitory Smad6 and Smad7 mRNA by TGF-β family members. Biochem Biophys Res Commun. 1998;249:505–511.PubMedCrossRef Afrakhte M, Morén A, Jossan S, et al. Induction of inhibitory Smad6 and Smad7 mRNA by TGF-β family members. Biochem Biophys Res Commun. 1998;249:505–511.PubMedCrossRef
20.
go back to reference Nakao A, Afrakhte M, Morn A, et al. Identification of Smad7, a TGF[beta]-inducible antagonist of TGF-[beta] signalling. Nature. 1997;389:631–635.PubMedCrossRef Nakao A, Afrakhte M, Morn A, et al. Identification of Smad7, a TGF[beta]-inducible antagonist of TGF-[beta] signalling. Nature. 1997;389:631–635.PubMedCrossRef
21.
go back to reference Moustakas A, Kardassis D. Regulation of the human p21/WAF1/Cip1 promoter in hepatic cells by functional interactions between Sp1 and Smad family members. Proc Natl Acad Sci USA. 1998;95:6733–6738.PubMedCrossRef Moustakas A, Kardassis D. Regulation of the human p21/WAF1/Cip1 promoter in hepatic cells by functional interactions between Sp1 and Smad family members. Proc Natl Acad Sci USA. 1998;95:6733–6738.PubMedCrossRef
22.
go back to reference Labbé E, Silvestri C, Hoodless PA, Wrana JL, Attisano L. Smad2 and Smad3 positively and negatively regulate TGFβ-dependent transcription through the forkhead DNA-binding protein FAST2. Mol Cell. 1998;2:109–120.PubMedCrossRef Labbé E, Silvestri C, Hoodless PA, Wrana JL, Attisano L. Smad2 and Smad3 positively and negatively regulate TGFβ-dependent transcription through the forkhead DNA-binding protein FAST2. Mol Cell. 1998;2:109–120.PubMedCrossRef
23.
go back to reference Liu C, Gaça MDA, Swenson ES, Vellucci VF, Reiss M, Wells RG. Smads 2 and 3 are differentially activated by transforming growth factor-β (TGF-β) in quiescent and activated hepatic stellate cells. J Biol Chem. 2003;278:11721–11728.PubMedCrossRef Liu C, Gaça MDA, Swenson ES, Vellucci VF, Reiss M, Wells RG. Smads 2 and 3 are differentially activated by transforming growth factor-β (TGF-β) in quiescent and activated hepatic stellate cells. J Biol Chem. 2003;278:11721–11728.PubMedCrossRef
24.
go back to reference Kim SG, Kim H-A, Jong H-S, et al. The endogenous ratio of Smad2 and Smad3 influences the cytostatic function of Smad3. Mol Biol Cell. 2005;16:4672–4683.PubMedCrossRef Kim SG, Kim H-A, Jong H-S, et al. The endogenous ratio of Smad2 and Smad3 influences the cytostatic function of Smad3. Mol Biol Cell. 2005;16:4672–4683.PubMedCrossRef
25.
go back to reference Sonoyama K, Rutatip S, Kasai T. Gene expression of activin, activin receptors, and follistatin in intestinal epithelial cells. Am J Physiol Gastrointest Liver Physiol. 2000;278:G89–G97.PubMed Sonoyama K, Rutatip S, Kasai T. Gene expression of activin, activin receptors, and follistatin in intestinal epithelial cells. Am J Physiol Gastrointest Liver Physiol. 2000;278:G89–G97.PubMed
26.
go back to reference Dignass AU, Jung S, Harder-d’Heureuse J, Wiedenmann B. Functional relevance of activin A in the intestinal epithelium. Scand J Gastroenterol. 2002;37:936–943.PubMedCrossRef Dignass AU, Jung S, Harder-d’Heureuse J, Wiedenmann B. Functional relevance of activin A in the intestinal epithelium. Scand J Gastroenterol. 2002;37:936–943.PubMedCrossRef
27.
go back to reference Zhang Y-Q, Resta S, Jung B, Barrett KE, Sarvetnick N. Upregulation of activin signaling in experimental colitis. Am J Physiol Gastrointest Liver Physiol. 2009;297:G768–G780.PubMedCrossRef Zhang Y-Q, Resta S, Jung B, Barrett KE, Sarvetnick N. Upregulation of activin signaling in experimental colitis. Am J Physiol Gastrointest Liver Physiol. 2009;297:G768–G780.PubMedCrossRef
28.
go back to reference Wildi S, Kleeff J, Maruyama H, Maurer CA, Büchler MW, Korc M. Overexpression of activin A in stage IV colorectal cancer. Gut. 2001;49:409–417.PubMedCrossRef Wildi S, Kleeff J, Maruyama H, Maurer CA, Büchler MW, Korc M. Overexpression of activin A in stage IV colorectal cancer. Gut. 2001;49:409–417.PubMedCrossRef
29.
go back to reference Hama K, Ohnishi H, Aoki H, et al. Angiotensin II promotes the proliferation of activated pancreatic stellate cells by Smad7 induction through a protein kinase C pathway. Biochem Biophys Res Commun. 2006;340:742–750.PubMedCrossRef Hama K, Ohnishi H, Aoki H, et al. Angiotensin II promotes the proliferation of activated pancreatic stellate cells by Smad7 induction through a protein kinase C pathway. Biochem Biophys Res Commun. 2006;340:742–750.PubMedCrossRef
Metadata
Title
Functional Roles of TGF-β1 in Intestinal Epithelial Cells Through Smad-Dependent and Non-Smad Pathways
Authors
Yumi Yamada
Hirosato Mashima
Toshitaka Sakai
Tamotsu Matsuhashi
Mario Jin
Hirohide Ohnishi
Publication date
01-05-2013
Publisher
Springer US
Published in
Digestive Diseases and Sciences / Issue 5/2013
Print ISSN: 0163-2116
Electronic ISSN: 1573-2568
DOI
https://doi.org/10.1007/s10620-012-2515-7

Other articles of this Issue 5/2013

Digestive Diseases and Sciences 5/2013 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.